Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial
Koh, Christopher, Dr, Canini, Laetitia, PhD, Dahari, Harel, PhD, Zhao, Xiongce, PhD, Uprichard, Susan L, PhD, Haynes-Williams, Vanessa, BSN, Winters, Mark A, MS, Subramanya, Gitanjali, MS, Cooper, Stewart L, MD, Pinto, Peter, MD, Wolff, Erin F, MD, Bishop, Rachel, MD, Ai Thanda Han, Ma, MD, Cotler, Scott J, Prof, Kleiner, David E, MD, Keskin, Onur, MD, Idilman, Ramazan, MD, Yurdaydin, Cihan, Prof, Glenn, Jeffrey S, MD, Heller, Theo, MBBch
Published in The Lancet infectious diseases (01.10.2015)
Published in The Lancet infectious diseases (01.10.2015)
Get full text
Journal Article